Lemaitre Vascular (LMAT) Raw Materials (2012 - 2026)

Lemaitre Vascular (LMAT) has 15 years of Raw Materials data on file, last reported at $21.2 million in Q1 2026.

• On a quarterly basis, Raw Materials rose 4.96% year-over-year to $21.2 million in Q1 2026; TTM through Mar 2026 was $21.2 million, a 4.96% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 9.33% from the prior year.
• Raw Materials for Q1 2026 stood at $21.2 million, up from $20.9 million in the prior quarter.
• Over the last five years, Raw Materials for LMAT reached as high as $21.7 million in Q2 2025 and fell as low as $12.5 million in Q1 2022.
• Historically, Raw Materials has averaged $18.3 million across 5 years, with a median of $19.1 million in 2024.
• Across the five-year window, Raw Materials soared 186.37% in 2022 and declined 3.08% in 2025, its largest moves.
• Year by year, Raw Materials stood at $14.9 million in 2022, then grew by 22.8% to $18.3 million in 2023, then climbed by 4.23% to $19.1 million in 2024, then rose by 9.33% to $20.9 million in 2025, then gained by 1.35% to $21.2 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $21.2 million in Q1 2026, $20.9 million in Q4 2025, and $21.0 million in Q3 2025.